期刊文献+

食管和贲门癌及癌前病变患者血清中cyclinB1、p62、Koc、IMP1和Survivin自身抗体检测及其在癌组织中表达变化特征

Detection of serum autoantibodies for cyclinB1, p62, Koc, IMP1 and Survivin in the subjects with esophageal and gastric cardia carcinoma and precancerous lesions and their expressions in the esophageal and gastric cardia cancer tissue.
原文传递
导出
摘要 目的探讨食管和贲门癌及癌前病变患者血清中cyclinB1、p62、Koc、IMP1和Survivin自身抗体检测及其在癌组织中表达变化特征。方法应用间接酶联免疫反应法和肿瘤相关抗原微阵列(包含5个重组的癌抗原蛋白cyclinB1、p62、Koc、IMP1和Survivin)检测376例食管和贲门各级病变患者(正常、癌前病变、癌)血清中的自身抗体;同时应用免疫组化ABC法检测与血清对应的13例食管癌和16例贲门癌组织中上述5个相关抗原。结果在5个抗原中,虽然cyclinB1、IMP1和p62从正常食管到癌前病变、癌患者血清中和p62在正常贲门到癌前病变、癌患者血清中阳性百分率均具有线性升高趋势(P〈0,05),但单一抗体对食管和贲门癌的检出率均较低,而当应用多个抗原分析时,即在5个肿瘤相关抗原中至少有一个反应为阳性时,与单一抗体比较食管癌和贲门癌的阳性检出率分别提高了3~5倍/3~4倍,并且,癌患者和食管、贲门各级病变患者血清阳性表达率差异显著(P〈0.05)。在癌组织中,5个抗原均有阳性表达,cyclinB1、Koc、IMP1和Survivin阳性率均明显高于血清抗体的检出率(P〈0.05),血清中抗体阳性的抗原在同一患者癌组织中均可测得。结论肿瘤自身抗体的产生与相关抗原的表达有关,联合应用多个肿瘤相关抗原比应用单个肿瘤相关抗原分析食管和贲门癌及癌前病变患者血清中的自身抗体变化更能提高癌和癌前病变患者的检出率。 Objective To characterize the alterations of serum autoantibodies for cyclinB1 ,p62, Koc,IMP1 and survivin in the subjects with esophageal and gastric cardia carcinoma and precancerous lesion and their expressions in the esophageal and gastric cardia cancer tissue. Methods Enzyme-linked immunoassay and tumor-associated antigen mini-array ( consisting of five full-length recombinant proteins, including cyclinB1, p62, Koc, IMP1 and Survivin) were applied to determine the serum level of the autoantibodies of these antigens on 376 subjects with esophageal and gastric cardia carcinoma and precancerous lesions. At the same time, the expression of these antigens was detected by immunohistochemical method (ABC) on 13 patients with esophageal cancer and 16 with gastric cardia cancer. Results All of the 5 antigens determined, the linear correlation was observed for the detection frequency of cyclinB1 ,IMP1 and p62 in esophageal carcinogenesis, and for p62 in gastric cardia multi-stage progression from normal to precancerous and cancerous lesions ( P 〈 0.05 ). The detection rate with single positive autoantibody immunoreactivitv for both esoohageal and gastric cardia cancers were low. However, the positive detection rate for both esophageal and gastric cardia cancer increased apparently when the multiple positive markers were combined together for analysis,which increased to 3 -5 and 3 -4 folds respectively. Furthermore,the difference in autoantibody immunoreactive rate was significant with the lesion progressed from mild to severe precancerous lesions and to cancer both in esophageal and gastric cardia cancers ( P 〈0.05 ). The positive immunoreactions of the 5 antigens were detected in cancer tissues. The positive immunostaining rates for cyclinBl, Koc, IMP1 and Survivin both in esophageal and gastric cardia cancers were higher compared to their serum positive rate of autoantibodies ( P 〈 0.05 ). Of the patients with positive immunostaining in the two cancer tissues,the autoantibodies in the serum for the corresponding antigens could be detected in the same patient. Conclusion The production of the tumor-associated autoantibodies is related to antigens. The screening rate through serum tumor-associated antigen mini-array for the patients with esophageal and gastric cardia carcinoma and precancerous lesions has been increased apparently with combined analysis of multiple autoantibodies than with single one.
出处 《中国综合临床》 北大核心 2008年第10期970-974,共5页 Clinical Medicine of China
基金 国家自然科学基金项目(30572115) 国家杰出青年科学基金项目(30025016) 河南省食管癌重点开放实验室基金项目(20050227) 河南省医学科技攻关项目(20058) 河南省高校创新人才工程基金项目(1999125) 郑州大学211工程项目
关键词 食管癌 贲门癌 肿瘤相关抗原 自身抗体 Esophageal carcinoma Carcinoma of gastric cardia Tumor-associated antigens Autoantibody
  • 相关文献

参考文献14

  • 1王立东,郑树.河南食管癌高发区人群食管和贲门癌变机制[J].郑州大学学报(医学版),2002,37(6):717-729. 被引量:101
  • 2Kao H ,Marto JA,Hoffmann TK,et al. Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells[ J]. J Exp Med,2001,194(9) :1313-1323.
  • 3Nielsen J,Christiansen J,Lykke-Andersen J, et al. A family of insulin-like growth factor Ⅱ mRNA-binding proteins represses translation in late development [ J ]. Mol Cell Biol, 1999,19 ( 2 ) : 1262-1270.
  • 4Rohayem J, Diestelkoetter P, Weigle B, et al. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients [ J ]. Cancer Res, 2000,60 ( 7 ) : 1815-1817.
  • 5Wang LD ,Shi ST,Zhou Q,et al. Changes in 1353 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis [J]. Int J Cancer, 1994,59 (4) :514-519.
  • 6Zhang JY, Casiano CA, Peng XX, et al. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens[ J]. Cancer Epidemiol Biomarkers Prey, 2003,12 ( 2 ) : 136- 143.
  • 7Wang LD, Hong JY, Qiu SL, et al. Accumulation of p53 protein in human esophageal precancerous lesions:a possible early biomarker for carcinogenesis [ J ]. Cancer Res, 1993,53 ( 8 ) : 1783-1787.
  • 8Shimizu M, Saitoh Y, hoh H. Immunohistochemical staining of Haras oncogene product in normal, benign, and malignant human pancreatic tissues[ J]. Hum Pathol, 1990,21 ( 6 ) :607-612.
  • 9Houghton AN. Cancer antigens :immune recognition of self and alted self[ J ]. J Exp Med, 1994,180 ( 1 ) : 1-4.
  • 10Soussi T. p53 antibodies in the sera of patients with various types of cancer. A review[J]. Cancer Res,2000,60 (7): 1777-1788.

二级参考文献21

  • 1李华川,陆士新.食管癌和贲门癌组织中p53基因突变的研究[J].中华肿瘤杂志,1994,16(3):172-176. 被引量:20
  • 2梁苑苑,陆士新,郭永军,赵新吉.林县食管癌中p53基因突变与p53高表达相关性的研究[J].中华肿瘤杂志,1995,17(6):412-414. 被引量:14
  • 3王立东,周琦,高珊珊,邢莹,李启驹,刘保池,裘宋良,Chung S.Yang.人食管和贲门癌前病变的细胞增生生物学指标研究[J].河南医科大学学报,1995,30(2):104-107. 被引量:7
  • 4A1-Kasspooles M, Moore JH,Orringer MB,et al. Amplification and over-expression of the EGFR and erbB2 genes in human esophageal adenocarcinomas. Int J Cancer, 1993,54(2) :213.
  • 5Greenblatt MS, Bennett WP, Hollstein M, et al. Mutation in the p53 tumor suppressor gene:clues to cancer etiology and molecular pathogenesis. Cancer Res, 1994,54 ( 18 ) :4 855.
  • 6Spruck CH, Gonzalek-Zulueta M, Shibata A, et al. p16 gene in uncultured tumors. Nature, 1994,370 ( 6 484) : 183.
  • 7Harper JW,Adami GR,Wei N,et al. The p21^WAF-1 cdk-4 interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinase. Cell, 1993,75 (4) :805.
  • 8Morgan RJ, Newcomb PV, Bailey M, et al. Loss of heterozygosity at microsatellite marker sites for tumor suppressor gene in esophageal adenocarcinoma. Eur J Surg Oncol, 1998,24(1) :34.
  • 9Ei-Diery WS ,Tokino T,Veleulesu V, et al. WAF1, a potential mediator of p53 tumor suppression. Cell, 1993,75 (4) :817.
  • 10Fearon EP, Vogelstein B. A genetic model for colorectal tumor genesis. Cell, 1990,61 ( 5 ) :759.

共引文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部